Logo image of AKTS

AKOUSTIS TECHNOLOGIES INC (AKTS) Stock Fundamental Analysis

NASDAQ:AKTS - Nasdaq - US00973N1028 - Common Stock - Currency: USD

0.0372  0 (-9.05%)

After market: 0.0177 -0.02 (-52.42%)

Fundamental Rating

1

AKTS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. AKTS has a bad profitability rating. Also its financial health evaluation is rather negative. AKTS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AKTS has reported negative net income.
In the past year AKTS has reported a negative cash flow from operations.
AKTS had negative earnings in each of the past 5 years.
In the past 5 years AKTS always reported negative operating cash flow.
AKTS Yearly Net Income VS EBIT VS OCF VS FCFAKTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

AKTS has a worse Return On Assets (-268.85%) than 98.40% of its industry peers.
Industry RankSector Rank
ROA -268.85%
ROE N/A
ROIC N/A
ROA(3y)-106.7%
ROA(5y)-81.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AKTS Yearly ROA, ROE, ROICAKTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800 1K

1.3 Margins

AKTS has a worse Gross Margin (15.97%) than 72.00% of its industry peers.
AKTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AKTS Yearly Profit, Operating, Gross MarginsAKTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

0

2. Health

2.1 Basic Checks

AKTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
AKTS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AKTS has been increased compared to 5 years ago.
Compared to 1 year ago, AKTS has a worse debt to assets ratio.
AKTS Yearly Shares OutstandingAKTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AKTS Yearly Total Debt VS Total AssetsAKTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -14.34, we must say that AKTS is in the distress zone and has some risk of bankruptcy.
AKTS's Altman-Z score of -14.34 is on the low side compared to the rest of the industry. AKTS is outperformed by 96.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.34
ROIC/WACCN/A
WACC2.38%
AKTS Yearly LT Debt VS Equity VS FCFAKTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 0.32 indicates that AKTS may have some problems paying its short term obligations.
AKTS has a Current ratio of 0.32. This is amonst the worse of the industry: AKTS underperforms 98.40% of its industry peers.
A Quick Ratio of 0.28 indicates that AKTS may have some problems paying its short term obligations.
AKTS has a Quick ratio of 0.28. This is amonst the worse of the industry: AKTS underperforms 97.60% of its industry peers.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.28
AKTS Yearly Current Assets VS Current LiabilitesAKTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for AKTS have decreased strongly by -49.48% in the last year.
The Revenue has been growing slightly by 2.97% in the past year.
AKTS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 80.23% yearly.
EPS 1Y (TTM)-49.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85%
Revenue 1Y (TTM)2.97%
Revenue growth 3Y60.53%
Revenue growth 5Y80.23%
Sales Q2Q%28.92%

3.2 Future

Based on estimates for the next years, AKTS will show a very strong growth in Earnings Per Share. The EPS will grow by 20.01% on average per year.
AKTS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.27% yearly.
EPS Next Y42.58%
EPS Next 2Y20.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.7%
Revenue Next 2Y34.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AKTS Yearly Revenue VS EstimatesAKTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
AKTS Yearly EPS VS EstimatesAKTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AKTS. In the last year negative earnings were reported.
Also next year AKTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AKTS Price Earnings VS Forward Price EarningsAKTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AKTS Per share dataAKTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

AKTS's earnings are expected to grow with 20.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.01%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AKTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKOUSTIS TECHNOLOGIES INC

NASDAQ:AKTS (12/17/2024, 8:40:32 PM)

After market: 0.0177 -0.02 (-52.42%)

0.0372

0 (-9.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)02-11 2025-02-11/amc
Inst Owners14.98%
Inst Owner Change-3.32%
Ins Owners2.52%
Ins Owner Change0%
Market Cap5.75M
Analysts45.71
Price Target0.26 (598.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.68%
Min Revenue beat(2)-21.61%
Max Revenue beat(2)10.25%
Revenue beat(4)1
Avg Revenue beat(4)-6.71%
Min Revenue beat(4)-21.61%
Max Revenue beat(4)10.25%
Revenue beat(8)1
Avg Revenue beat(8)-5%
Revenue beat(12)1
Avg Revenue beat(12)-5.68%
Revenue beat(16)3
Avg Revenue beat(16)-3.56%
PT rev (1m)-60%
PT rev (3m)-66.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.3%
EPS NY rev (1m)-14.29%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-28.98%
Revenue NY rev (1m)-2.26%
Revenue NY rev (3m)-2.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.42
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.19
BVpS-0.42
TBVpS-0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -268.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.97%
FCFM N/A
ROA(3y)-106.7%
ROA(5y)-81.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.99%
Cap/Sales 6.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.28
Altman-Z -14.34
F-Score3
WACC2.38%
ROIC/WACCN/A
Cap/Depr(3y)199.27%
Cap/Depr(5y)237.78%
Cap/Sales(3y)97.95%
Cap/Sales(5y)207.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85%
EPS Next Y42.58%
EPS Next 2Y20.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.97%
Revenue growth 3Y60.53%
Revenue growth 5Y80.23%
Sales Q2Q%28.92%
Revenue Next Year29.7%
Revenue Next 2Y34.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.97%
OCF growth 3YN/A
OCF growth 5YN/A